Under the licensing agreement, Alkem will carry out the clinical development of “SON-080” in India with support from Sonnet and enable global and India regulatory filings
DKSH has entered into an exclusive partnership with R-Biomeds to bring the necessary medication to patients in Cambodia
CSPC will receive an upfront payment of $100 million from AstraZeneca
Gilead Sciences first launched Lenacapavir under the brand name Sunlenca in the United States and Europe markets in the year 2022
Agreement enables access of EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders to patients from Argentina and Colombia
Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita
The product is an additional formulation of Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg
The exclusive hospital will help address health complexities concerning women and children, specializing in high-end obstetrics, comprehensive gynecological, neonatal & pediatric care
Fermenta Biotech’s API manufacturing facility receives EU GMP compliance certificate
Takeda has granted Lupin non-exclusive patent licensing rights to commercialize Vonoprazan in India
Subscribe To Our Newsletter & Stay Updated
